siRNA therapy reduces triglycerides in individuals along with unusual problem

.ANALYSIS FEATURE.19 September 2024.

Plozasiran minimized triglyceride amounts through 80% and also lowered the threat of pancreatitis in individuals with chronic chylomicronemia, with or even without a genetic medical diagnosis.